Cipla

In News

India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar - reuters.com

reuters.com - Sep 03, 2026

Cipla Receives U.S. FDA Approval for Generic Advair Diskus® - PR Newswire

PR Newswire - Jul 28, 2026

FDA cancels drug sale licences of Cipla Pharma & Life Sciences' Pune Carry and Forwarding unit - The Hindu

The Hindu - Aug 28, 2026

Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab) in the US - Nasdaq

Nasdaq - Sep 03, 2026

Cipla Pune Unit's Drug Sale Licence Cancelled Over 'Irregularities' - NDTV

NDTV - Aug 29, 2026

Cipla Partners With Qilu Pharmaceutical to Commercialize a Keytruda Biosimilar in the US - BioPharm International

BioPharm International - Sep 04, 2026

Indian Export Stocks Facing A US Tariff Reset Investors Should Not Ignore - simplywall.st

simplywall.st - Sep 19, 2026

FDA cancels Cipla pharma’s CFA drug sale licence in Pune - The Indian Express

The Indian Express - Aug 28, 2026

Cipla Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs

Revelio Labs - Jul 28, 2026

Cipla partners with Qilu to bring a Keytruda biosimilar to the US - Dealroom

Dealroom - Sep 04, 2026

As Cipla Chases US Milestone, gVentolin Scale-up Is Key - insights.citeline.com

insights.citeline.com - Jul 24, 2026

FDA crackdown on Cipla Pharma's Pune unit, license cancelled over 'unauthorised promotional text' | India News - Hindustan Times

Hindustan Times - Aug 28, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment